Inhibition of cyclophosphamide-induced teratogenesis by β-ionone

被引:23
|
作者
Gomes-Carneiro, MR
De-Oliveira, ACAX
De-Carvalho, RR
Araujo, IB
Souza, CAM
Kuriyama, SN
Paumgartten, FJR
机构
[1] Fiocruz MS, Escola Nacl Saude Publ, Lab Toxicol Ambiental, Oswaldo Cruz Fdn, BR-21040361 Rio De Janeiro, RJ, Brazil
[2] Univ Fed Fluminense, Fac Vet Med, Niteroi, RJ, Brazil
关键词
metabolic activation; cytochrome P450; essential oils; developmental toxicity; pentobarbital; terpenoid compounds;
D O I
10.1016/S0378-4274(02)00413-7
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
beta-lonone (111) is a degraded (C 13) sesquiterpene found in plant essential oils. It has been used in the synthesis of perfume chemicals and vitamin A. Recently, it was reported that BI is a rather potent in vitro inhibitor of CYP2B1-catalysed reactions in rat liver microsomes. The present study was performed to investigate whether inhibition of CYP2B1 reactions by BI could lead to an attenuation of cyclophosphamide (CP)-induced embryotoxicity in the rat. In a preliminary experiment, a dose-dependent prolongation of pentobarbital sleeping time in male and female Wistar rats suggested that BI inhibits CYP2B1 in vivo as well. In a second experiment, rats were treated by gavage with BI (0, 250, 500, 750 or 1000 mg/kg body wt) 45 min prior to a subcutaneous injection of either CP (7.5 mg/kg body wt) or its vehicle (saline) on day I I of pregnancy. BI alone, at the highest dose tested, caused a high proportion of resorptions. Lower doses of BI, however, clearly attenuated CP-induced embryolethality and teratogenicity. These results seem to support the view that, as far as rats are concerned, CYP2B1 plays an import-ant role in the conversion of CP into its embryolethal and teratogenic metabolites. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 50 条
  • [1] Cyclophosphamide-induced teratogenesis in ICR mice: The role of apoptosis
    Torchinsky, A
    Savion, S
    Gorivodsky, M
    Shepshelovich, J
    Zaslavsky, Z
    Fein, A
    Toder, V
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS, 1995, 15 (04): : 179 - 190
  • [2] Preventive Effect of Piperonyl Butoxide on Cyclophosphamide-Induced Teratogenesis in Rats
    Park, Dongsun
    Kim, Sunghyun
    Kang, Hyomin
    Oh, Jiyoung
    Jang, Ja Young
    Shin, Sunhee
    Kim, Tae Kyun
    Choi, Young Jin
    Lee, Sun Hee
    Kim, Ki-Yon
    Joo, Seong Soo
    Kim, Yun-Bae
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2009, 86 (05) : 402 - 408
  • [3] Cell-cycle alterations underlie cyclophosphamide-induced teratogenesis in the chick embryo
    Heringová, L
    Jelínek, R
    Dostál, M
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2003, 67 (06) : 438 - 443
  • [4] Cyclophosphamide-induced methemoglobinemia
    N Shehadeh
    R Dansey
    S Seen
    E Abella
    Bone Marrow Transplantation, 2003, 32 : 1109 - 1110
  • [5] CYCLOPHOSPHAMIDE-INDUCED CHIMERISM
    GLYNN, JP
    FEFER, A
    HALPERN, BL
    CANCER RESEARCH, 1968, 28 (01) : 41 - &
  • [6] CYCLOPHOSPHAMIDE-INDUCED MYOPIA
    ARRANZ, JA
    JIMENEZ, R
    ALVAREZMON, M
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) : 92 - 93
  • [7] Cyclophosphamide-induced methemoglobinemia
    Shehadeh, N
    Dansey, R
    Seen, S
    Abella, E
    BONE MARROW TRANSPLANTATION, 2003, 32 (11) : 1109 - 1110
  • [8] Effect of naturally occurring isothiocyanates in the inhibition of cyclophosphamide-induced urotoxicity
    Manesh, C
    Kuttan, G
    PHYTOMEDICINE, 2005, 12 (6-7) : 487 - 493
  • [9] Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats
    Andrzej Wróbel
    Urszula Doboszewska
    Ewa Rechberger
    Karol Rojek
    Anna Serefko
    Ewa Poleszak
    Krystyna Skalicka-Woźniak
    Jarosław Dudka
    Piotr Wlaź
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 613 - 619
  • [10] Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats
    Wrobel, Andrzej
    Doboszewska, Urszula
    Rechberger, Ewa
    Rojek, Karol
    Serefko, Anna
    Poleszak, Ewa
    Skalicka-Wozniak, Krystyna
    Dudka, Jaroslaw
    Wlaz, Piotr
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (06) : 613 - 619